HLA Protein Technologies Inc.

HLA Protein Technologies develops and manufactures validated soluble HLA Class I & II molecules and related services — quantitative peptide binding, epitope mapping, immune-target validation, and transplant antibody assay development for the development of immunotherapeutics and vaccines.
​
Purchase on Scientist.com
​

Subscribe to our newsletter

Subscribe to receive the latest news and innovations straight to your inbox.

The Latest Insights & Innovations from

HLA Protein Technologies Inc.

Webinars
Blogs
Podcasts
​
ON DEMAND
​
Webinar

De-Risking Immunotherapy Targets with Next-Gen HLA Discovery Platforms

March 25, 2026
Learn more
No items found.
No items found.
​
See it in Action

The Digital Backbone for Modern Life Sciences

Discover how one intelligent platform helps teams connect providers, workflows, approvals, compliance, data, and spend—so complex projects move faster with greater visibility and control.

​
Request a Personalized Demo